FDA Inspection 1105823 — Aurobindo Pharma Limited
The FDA completed an inspection of Aurobindo Pharma Limited on Sep 27, 2019 in Jedcherla Mandal, Mahabubnagar. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Sep 27, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jedcherla Mandal, Mahabubnagar (India)